Cross-source evidence timeline
Cerebrolysin research timeline
Follow 47 selected, directly cited source records from December 28, 2010 through November 14, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
Longitudinal Serum and Cerebrospinal Fluid S100B Concentrations After Aneurysmal Subarachnoid Hemorrhage: An Exploratory Comparison of Historical Cohorts With and Without Cerebrolysin Exposure.↗
PubMed lists PMID 43030876 in Journal of clinical medicine as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 9, 2026 · day precisionAdded to PeptideScanner November 17, 2026Literature metadata
Cerebrolysin: a review of its use in dementia.↗
PubMed lists PMID 19848437 in Drugs & aging as Journal Article, Review, with publication-date metadata of 2009 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2009 · year precisionAdded to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series.↗
PubMed lists PMID 33620612 in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology as Journal Article, Meta-Analysis, with publication-date metadata of 2021-02-23 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 23, 2021 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07846488↗
PeptideScanner retained ClinicalTrials.gov record NCT07846488 at 2026-11-16T17:33:14.861Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.↗
PubMed lists PMID 37892776 in Journal of clinical medicine as Journal Article, Review, with publication-date metadata of 2023-10-20 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 20, 2023 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06339411↗
PeptideScanner retained ClinicalTrials.gov record NCT06339411 at 2026-11-16T17:33:14.861Z. Its registry update date was 2026-08-11, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Literature metadata
The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts.↗
PubMed lists PMID 39832667 in Neuroscience as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-01-19 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 19, 2025 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04427241↗
PeptideScanner retained ClinicalTrials.gov record NCT04427241 at 2026-11-16T17:33:14.861Z. Its registry update date was 2026-05-11, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Literature metadata
[Cerebrolysin for acute ischemic stroke].↗
PubMed lists PMID 23805635 in Vestnik Rossiiskoi akademii meditsinskikh nauk as Journal Article, Review, with publication-date metadata of 2013 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2013 · year precisionAdded to PeptideScanner November 16, 2026Literature metadata
Cerebroprotection in acute ischemic stroke: Perspectives on combining cerebrolysin with recanalization therapy.↗
PubMed lists PMID 41349847 in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association as Journal Article, Review, with publication-date metadata of 2025-12-03 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 3, 2025 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2025
Clinical trials
ClinicalTrials.gov record NCT06052787↗
PeptideScanner retained ClinicalTrials.gov record NCT06052787 at 2026-11-16T17:33:14.861Z. Its registry update date was 2025-11-19, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05821075↗
PeptideScanner retained ClinicalTrials.gov record NCT05821075 at 2026-11-16T17:33:14.861Z. Its registry update date was 2025-07-31, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin for vascular dementia.↗
PubMed lists PMID 23440834 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2013-01-31 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 31, 2013 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin for acute ischaemic stroke.↗
PubMed lists PMID 26083192 in The Cochrane database of systematic reviews as Journal Article, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2015-06-17 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 17, 2015 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
[Cerebrolysin with reperfusion therapy in ischemic stroke: a prospective analysis of multimodal brain imaging data from the CEREHETIS trial].↗
PubMed lists PMID 40577185 in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova as Journal Article, Randomized Controlled Trial, English Abstract, with publication-date metadata of 2025 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2025 · year precisionAdded to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin for acute ischaemic stroke.↗
PubMed lists PMID 20393954 in The Cochrane database of systematic reviews as Journal Article, Systematic Review, with publication-date metadata of 2010-04-14 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 14, 2010 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin for acute ischaemic stroke.↗
PubMed lists PMID 27918088 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2016-12-05 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 5, 2016 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin for acute ischaemic stroke.↗
PubMed lists PMID 37818733 in The Cochrane database of systematic reviews as Systematic Review, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-10-11 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: October 11, 2023 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin for acute ischaemic stroke.↗
PubMed lists PMID 28430363 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2017-04-21 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 21, 2017 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin for acute ischaemic stroke.↗
PubMed lists PMID 32662068 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2020-07-14 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 14, 2020 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03480698↗
PeptideScanner retained ClinicalTrials.gov record NCT03480698 at 2026-11-16T17:33:14.861Z. Its registry update date was 2025-02-25, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05755997↗
PeptideScanner retained ClinicalTrials.gov record NCT05755997 at 2026-11-16T17:33:14.861Z. Its registry update date was 2025-02-25, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026
Source year
2024
Clinical trials
ClinicalTrials.gov record NCT06677502↗
PeptideScanner retained ClinicalTrials.gov record NCT06677502 at 2026-11-16T17:33:14.861Z. Its registry update date was 2024-12-31, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin for vascular dementia.↗
PubMed lists PMID 31710397 in The Cochrane database of systematic reviews as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2019-11-11 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 11, 2019 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06208540↗
PeptideScanner retained ClinicalTrials.gov record NCT06208540 at 2026-11-16T17:33:14.861Z. Its registry update date was 2024-08-05, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT00947531↗
PeptideScanner retained ClinicalTrials.gov record NCT00947531 at 2026-11-16T17:33:14.861Z. Its registry update date was 2024-02-21, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026
Source year
2023
Clinical trials
ClinicalTrials.gov record NCT00868283↗
PeptideScanner retained ClinicalTrials.gov record NCT00868283 at 2026-11-16T17:33:14.861Z. Its registry update date was 2023-12-15, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Literature metadata
Noninvasive monitoring in a patient with SAH diagnosis treated with Cerebrolysin - case report and review of the literature.↗
PubMed lists PMID 37522695 in European review for medical and pharmacological sciences as Review, Case Reports, Journal Article, with publication-date metadata of 2023-07 (month precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 2023 · month precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05807503↗
PeptideScanner retained ClinicalTrials.gov record NCT05807503 at 2026-11-16T17:33:14.861Z. Its registry update date was 2023-04-11, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis.↗
PubMed lists PMID 36979317 in Brain sciences as Journal Article, Review, with publication-date metadata of 2023-03-17 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 17, 2023 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04830943↗
PeptideScanner retained ClinicalTrials.gov record NCT04830943 at 2026-11-16T17:33:14.861Z. Its registry update date was 2023-01-03, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026
Source year
2022
Literature metadata
Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study.↗
PubMed lists PMID 11738849 in Brain & development as Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2001-12 (month precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 2001 · month precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05288465↗
PeptideScanner retained ClinicalTrials.gov record NCT05288465 at 2026-11-16T17:33:14.861Z. Its registry update date was 2022-03-21, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026
Source year
2021
Literature metadata
Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine.↗
PubMed lists PMID 33223037 in Progress in brain research as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2020-11-09 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 9, 2020 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use.↗
PubMed lists PMID 32808294 in Medicinal research reviews as Journal Article, Review, with publication-date metadata of 2020-08-17 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 17, 2020 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT03506841↗
PeptideScanner retained ClinicalTrials.gov record NCT03506841 at 2026-11-16T17:33:14.861Z. Its registry update date was 2021-03-15, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT04751136↗
PeptideScanner retained ClinicalTrials.gov record NCT04751136 at 2026-11-16T17:33:14.861Z. Its registry update date was 2021-02-11, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026
Source year
2020
Clinical trials
ClinicalTrials.gov record NCT02149875↗
PeptideScanner retained ClinicalTrials.gov record NCT02149875 at 2026-11-16T17:33:14.861Z. Its registry update date was 2020-08-24, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026
Source year
2019
Clinical trials
ClinicalTrials.gov record NCT02768571↗
PeptideScanner retained ClinicalTrials.gov record NCT02768571 at 2026-11-16T17:33:14.861Z. Its registry update date was 2019-09-20, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026Literature metadata
The role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: new potentials for neuroprotection with Cerebrolysin therapy.↗
PubMed lists PMID 24730284 in Journal of nanoscience and nanotechnology as Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2014-01 (month precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 2014 · month precisionAdded to PeptideScanner November 16, 2026Literature metadata
Cerebrolysin: a multi-target drug for recovery after stroke.↗
PubMed lists PMID 30004268 in Expert review of neurotherapeutics as Journal Article, Review, with publication-date metadata of 2018-07-18 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 18, 2018 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Role of Cerebrolysin in cervical spondylotic myelopathy patients: a prospective randomized study.↗
PubMed lists PMID 29155000 in The spine journal : official journal of the North American Spine Society as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2017-11-14 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 14, 2017 · day precisionAdded to PeptideScanner November 16, 2026
Source year
2016
Literature metadata
[Efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus].↗
PubMed lists PMID 21350421 in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova as Controlled Clinical Trial, Journal Article, with publication-date metadata of 2011 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2011 · year precisionAdded to PeptideScanner November 16, 2026Literature metadata
[Cerebrolysin in the treatment of brain injuries of moderate severity].↗
PubMed lists PMID 25591645 in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova as Controlled Clinical Trial, Journal Article, with publication-date metadata of 2014 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2014 · year precisionAdded to PeptideScanner November 16, 2026
Source year
2013
Clinical trials
ClinicalTrials.gov record NCT01059461↗
PeptideScanner retained ClinicalTrials.gov record NCT01059461 at 2026-11-16T17:33:14.861Z. Its registry update date was 2013-09-13, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026
Source year
2011
Clinical trials
ClinicalTrials.gov record NCT01388738↗
PeptideScanner retained ClinicalTrials.gov record NCT01388738 at 2026-11-16T17:33:14.861Z. Its registry update date was 2011-12-23, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026
Source year
2010
Clinical trials
ClinicalTrials.gov record NCT00840671↗
PeptideScanner retained ClinicalTrials.gov record NCT00840671 at 2026-11-16T17:33:14.861Z. Its registry update date was 2010-12-28, and PeptideScanner's reviewed identity mapping was cerebrolysin.↗
Added to PeptideScanner November 16, 2026